Gabriella Pietra Selected Research

Gabriella Pietra Research Topics

Disease

28	Neoplasms (Cancer) 01/2023 - 08/2002
15	Melanoma (Melanoma, Malignant) 02/2023 - 03/2009
7	Leukemia 01/2021 - 01/2014
3	Infections 01/2021 - 12/2017
2	Hypoxia (Hypoxemia) 06/2022 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2018
1	Carcinoma (Carcinomatosis) 08/2019
1	Tuberculosis (Tuberculoses) 04/2015
1	HIV Infections (HIV Infection) 04/2015
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2014

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2023 - 12/2009
6	Interleukin-15 (Interleukin 15)IBA 01/2023 - 09/2016
5	Protein Isoforms (Isoforms)IBA 01/2023 - 03/2009
5	LigandsIBA 06/2022 - 01/2014
3	VemurafenibIBA 01/2023 - 01/2020
3	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2020
3	Interleukin-2 (IL2)IBA 08/2019 - 05/2013
3	Monoclonal AntibodiesIBA 01/2019 - 05/2013
2	AntigensIBA 01/2021 - 10/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 12/2017
2	NivolumabIBA 01/2020 - 01/2019
2	Syndecan-1 (Syndecan 1)IBA 08/2019 - 11/2015
2	L19-IL2 immunocytokineIBA 08/2019 - 11/2015
2	Fibronectins (Fibronectin)IBA 08/2019 - 11/2015
2	EpitopesIBA 12/2017 - 03/2009
2	Peptides (Polypeptides)IBA 04/2015 - 03/2009
1	Cell-Free Nucleic AcidsIBA 02/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	NAD (NADH)IBA 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	Heme Oxygenase-1IBA 06/2022
1	Oxygen (Dioxygen)IBA 06/2022
1	Therapeutic UsesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2020
1	Proteins (Proteins, Gene)FDA Link 08/2019
1	AntibodiesIBA 01/2019
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	matrigelIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Histocompatibility Antigens Class IIBA 10/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2016
1	mirdametinibIBA 09/2016
1	Interleukin-18 (Interleukin 18)IBA 09/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016
1	EnzymesIBA 04/2016
1	Chemotactic FactorsIBA 12/2015
1	HMGB1 Protein (HMG1)IBA 12/2015
1	Natural Killer Cell ReceptorsIBA 12/2015
1	PerforinIBA 12/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 11/2015
1	Mycobacterium tuberculosis antigensIBA 04/2015
1	Proto-Oncogene Proteins c-metIBA 06/2014
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 06/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 06/2014
1	Messenger RNA (mRNA)IBA 05/2013
1	IpilimumabIBA 05/2013
1	Prostaglandins EIBA 12/2009
1	Adapalene (Differin)FDA LinkGeneric 07/2009
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 07/2009
1	PeroxiredoxinsIBA 03/2009
1	Peroxidase (Myeloperoxidase)IBA 03/2009
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2002
1	KIR ReceptorsIBA 08/2002

Therapy/Procedure

20	Therapeutics 02/2023 - 01/2014
8	Immunotherapy 10/2022 - 10/2013
4	Hematopoietic Stem Cell Transplantation 01/2021 - 04/2016
2	Transplantation 01/2019 - 01/2014
1	Investigational Therapies (Experimental Therapy) 03/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Immunomodulation 12/2015